BioStem Technologies (BioStem Technologies) Revenue : $4.97 Mil (TTM As of Sep. 2023)

View and export this data going back to 2008. Start your Free Trial

What is BioStem Technologies Revenue?

BioStem Technologies's revenue for the three months ended in Sep. 2023 was $3.60 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $4.97 Mil. BioStem Technologies's Revenue per Share for the three months ended in Sep. 2023 was $0.27. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $0.37.

Warning Sign:

BioStem Technologies Inc revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of BioStem Technologies was -6.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was 28.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 51.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, BioStem Technologies's highest 3-Year average Revenue per Share Growth Rate was 64.30% per year. The lowest was -88.70% per year. And the median was 17.50% per year.

BioStem Technologies Revenue Historical Data

The historical data trend for BioStem Technologies's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioStem Technologies Revenue Chart

BioStem Technologies Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Revenue

Get a 7-Day Free Trial

1.02

2.63

2.52

4.34

6.88

BioStem Technologies Quarterly Data
	Sep15	Dec15	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Dec21	Mar22	Sep22	Dec22	Mar23	Sep23
Revenue	Get a 7-Day Free Trial															2.78	1.15	0.79	0.58	3.60

Competitive Comparison of BioStem Technologies's Revenue

For the Biotechnology subindustry, BioStem Technologies's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioStem Technologies's Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioStem Technologies's Revenue distribution charts can be found below:

* The bar in red indicates where BioStem Technologies's Revenue falls into.

BioStem Technologies Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.97 Mil.

BioStem Technologies (OTCPK:BSEM) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

BioStem Technologies Revenue Related Terms

Thank you for viewing the detailed overview of BioStem Technologies's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

BioStem Technologies (BioStem Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioStem Technologies Inc (OTCPK:BSEM) » Definitions » Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

2836 Center Port Circle, Pompano Beach, FL, USA, 33064

Website

https://www.biostemtechnologies.com

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Its proprietary approach, Local MicroEnvironment Activation, uses combinations of Small Molecules, Cytokines, and Growth Factors to activate the microenvironment within the body to create communication for repair in the tissue. The Company offers a comprehensive portfolio of high-quality brands that are trademarked and include RHEO, AEON, OROPRO, VENDAJE, VENDAJE AC, and VENDAJE OPTIC.